Most APPs treating heart failure right now are practicing off a guideline that’s three years out of date, and don’t know it.
Ask one what the four pillars of heart failure treatment are, and you’ll usually get three right answers fast, then a pause on the fourth. Beta-blockers. ACE inhibitors or ARBs. Mineralocorticoid receptor antagonists. Those land immediately; they’ve been standard for years. SGLT2 inhibitors as a foundational therapy for every patient with reduced ejection fraction heart failure, diabetic or not? That one still catches people. It shouldn’t. The 2022 AHA/ACC/HFSA heart failure guideline made it a Class 1 recommendation. (I had to double-check that year before writing this sentence, which is more or less the whole point.) That’s three years old now. It’s not new information anymore. It’s information that hasn’t reached everyone who’s supposed to be using it.
That’s not a knock on any one clinician. It’s a structural problem, and I think it’s a bigger one than anyone in nursing or medical education wants to admit.
Continuing education was built to solve a different problem. It exists to prove a clinician kept learning after they got licensed, so the hour requirement gets satisfied and the license gets renewed. What it was never built to do is verify that a clinician’s actual working knowledge of a specific guideline is current. You can accumulate every required CME hour for a renewal cycle and never touch the one update that changed how you should be treating the patient in front of you tomorrow morning. Hours and currency are not the same thing, and the system tracks the one it can measure.
I see the gap constantly in cardiology. An APP trained five or ten years ago learned heart failure management as ACE inhibitor, beta-blocker, spironolactone if needed, diuretics for volume. That was the correct answer when they learned it. Nobody sent a notification when the correct answer changed. There’s no built-in trigger that says the guideline you memorized in your program is no longer the guideline in current use, go relearn this specific piece. You find out by accident. A colleague mentions it. A pharmacist raises an eyebrow at your order. You happen to read the right article at the right time. Or you don’t find out, and you keep practicing on the version you learned.
Say what you will about individual effort. Plenty of clinicians work hard to stay current. The system still doesn’t help them do it. It measures hours, not currency. A clinician can be fully compliant with every licensing requirement and still be working from a heart failure guideline that’s two revisions behind.
Heart failure isn’t a special case either. The same pattern shows up in atrial fibrillation stroke-risk scoring, in blood pressure targets, in when to start statin therapy. Guidelines get revised on a real cadence, usually every three to five years, and each revision assumes the clinicians using it will find out. Most of the time, they find out eventually. The question is how many patients get managed on the old version in the meantime.
The gap widens the further someone gets from training. New graduates get whatever’s current because it’s what’s in this year’s textbook. Ten years out, that same person is working from whatever was current when they were a student, patched only by whatever they happened to catch along the way. Training programs don’t have a mechanism to re-teach their own alumni. CME providers don’t have a mechanism to verify that a specific piece of knowledge got refreshed instead of a credit hour got logged. The paperwork can be perfect and the actual clinical decision-making can still be years behind.
What would close that gap isn’t another mandatory course. Nobody’s signing up for elective SGLT2i continuing education on their own initiative. They don’t know they need it. That’s the whole problem. What closes it is building guideline currency into the tools clinicians already use to think through a case, so the update reaches someone at the moment they’re making a decision, not at the moment they’re renewing a license.
That’s the specific gap I built the guideline injection into NursingEdAI to close. When it generates a practice question or a case study, it pulls the current version of the applicable clinical practice guideline into the process automatically, tied to the actual source document, not a textbook citation from five years ago.
Beta-blockers, ACE inhibitors, MRAs, SGLT2 inhibitors. Four pillars. If the fourth one still catches you, that’s not a personal failing. It’s a sign that the system responsible for keeping you current didn’t do its job. The guideline changed in 2022. Most of us are still practicing off the version we memorized, and nobody’s coming to tell us otherwise.